HDIM
SEEL
Hanson & Doremus Investment Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-1,000
| Closed | – | – | 470 |
|
2016
Q3 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 455 |
|
2016
Q2 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 463 |
|
2016
Q1 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 453 |
|
2015
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 463 |
|
2015
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 448 |
|
2015
Q2 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 433 |
|
2015
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 448 |
|
2014
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 448 |
|
2014
Q3 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 416 |
|
2014
Q2 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 409 |
|
2014
Q1 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 404 |
|
2013
Q4 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 411 |
|
2013
Q3 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 390 |
|
2013
Q2 | $2K | Buy |
+1,000
| New | +$2K | ﹤0.01% | 353 |
|